Revolution Medicines, Inc. (RVMD) /
The profitability of Revolution Medicines, Inc. over the past 8 years
Chart Revolution Medicines, Inc.: operating income, net income, fiscal 2018–2025 Open the chart →Revolution Medicines, Inc. reported a net loss of $1.13B in fiscal 2025, the latest fiscal year on file. That year it had an operating loss of $1.18B. It reported a loss in all 8 years shown.
Year by year
| Fiscal year | Operating income | Net income |
|---|---|---|
| 2025ended Dec 31, 2025 | -$1.18B | -$1.13B |
| 2024ended Dec 31, 2024 | -$689.52M | -$600.09M |
| 2023ended Dec 31, 2023 | -$487.19M | -$436.37M |
| 2022ended Dec 31, 2022 | -$258.28M | -$248.71M |
| 2021ended Dec 31, 2021 | -$188.01M | -$187.09M |
| 2020ended Dec 31, 2020 | -$110.7M | -$108.16M |
| 2019ended Dec 31, 2019 | -$54.12M | -$47.66M |
| 2018ended Dec 31, 2018 | -$40.33M | -$41.79M |
Fiscal years as Revolution Medicines, Inc. reports them. * Calculated by us from the company's filed figures; — no figure on file. From SEC filings, updated nightly. How each line is read.
More on Revolution Medicines, Inc.
- The revenue of Revolution Medicines, Inc.
- The cash flow of Revolution Medicines, Inc.
- The debt of Revolution Medicines, Inc.
- All of Revolution Medicines, Inc.'s financials, charted
Companies of a similar size
- ELTHE ESTEE LAUDER COMPANIES INC.
- NBISNEBIUS GROUP N.V.
- PRUPRUDENTIAL FINANCIAL INC
- SYYSysco Corporation
- STMSTMicroelectronics N.V.
Not investment advice. This page shows what Revolution Medicines, Inc. filed with the SEC. Nothing here is a recommendation about any security. Check important figures against the company's own filings.